Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results

Go back to Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
(NYSE: CLDI) Delayed: 0.09 --0 (-0%)
Previous Close $0.09    52 Week High
Open $0.09    52 Week Low
Day High $0.09    P/E N/A 
Day Low $0.09    EPS
Volume 9,369